These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15703097)

  • 1. The use and rationale of selective alpha blockade in children with non-neurogenic neurogenic bladder dysfunction.
    Bogaert G; Beckers G; Lombaerts R
    Int Braz J Urol; 2004; 30(2):128-34. PubMed ID: 15703097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
    Cain MP; Wu SD; Austin PF; Herndon CD; Rink RC
    J Urol; 2003 Oct; 170(4 Pt 2):1514-5; discussion 1516-7. PubMed ID: 14501648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study.
    Yucel S; Akkaya E; Guntekin E; Kukul E; Akman S; Melikoglu M; Baykara M
    J Urol; 2005 Oct; 174(4 Pt 2):1612-5; discussion 1615. PubMed ID: 16148665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The non-neurogenic neurogenic bladder (Hinman's syndrome) in children: What are pronostic criteria based on a 31 cases multicentric study].
    Claudon P; Fotso-Kamdem A; Aubert D
    Prog Urol; 2010 Apr; 20(4):292-300. PubMed ID: 20380992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index.
    Gül O; Eroğlu M; Ozok U
    Int Urol Nephrol; 2001; 32(3):433-6. PubMed ID: 11583367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction.
    Austin PF; Homsy YL; Masel JL; Cain MP; Casale AJ; Rink RC
    J Urol; 1999 Sep; 162(3 Pt 2):1064-7. PubMed ID: 10458432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.
    Van Batavia JP; Combs AJ; Horowitz M; Glassberg KI
    J Urol; 2010 Feb; 183(2):724-30. PubMed ID: 20022041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study.
    Lacquaniti S; Destito A; Servello C; Candidi MO; Weir JM; Brisinda G; Alcini E
    Arch Ital Urol Androl; 1999 Dec; 71(5):283-5. PubMed ID: 10673791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
    Vanderbrink BA; Gitlin J; Toro S; Palmer LS
    J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terazosin in the treatment of premature ejaculation: a short-term follow-up.
    Başar MM; Yilmaz E; Ferhat M; Başar H; Batislam E
    Int Urol Nephrol; 2005; 37(4):773-7. PubMed ID: 16362597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical efficacy and safety of terazosine (setegis) in patients with benign prostatic hyperplasia with concomitant cardiovascular diseases].
    Trapeznikova MF; Gurevich MA; Pozdniakov KV; Tazina SIa; Bychkova NV
    Urologiia; 2005; (2):50-3. PubMed ID: 15989029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study].
    Koyanagi T; Togashi M; Maru A; Orikasa S; Soma F; Shimazaki J; Yasuda K; Aso Y; Honma Y; Miyake K
    Hinyokika Kiyo; 1990 Oct; 36(10):1233-52. PubMed ID: 1979900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction--Preliminary Findings.
    Kroll P; Gajewska E; Zachwieja J; Sobieska M; Mańkowski P
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26999168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary incontinence in children: suggestions for definitions and terminology.
    Hjälmås K
    Scand J Urol Nephrol Suppl; 1992; 141():1-6; discussion 18-9. PubMed ID: 1609244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional elimination syndrome as an etiology of idiopathic urethritis in childhood.
    Herz D; Weiser A; Collette T; Reda E; Levitt S; Franco I
    J Urol; 2005 Jun; 173(6):2132-7. PubMed ID: 15879866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
    Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
    J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of alpha1-adrenergic blockers in boys with low urinary flow rate and urinary incontinence.
    Yang SS; Wang CC; Chen YT
    J Formos Med Assoc; 2003 Aug; 102(8):551-5. PubMed ID: 14569320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability.
    Petersen T; Husted SE; Sidenius P
    Scand J Urol Nephrol; 1989; 23(3):189-94. PubMed ID: 2678426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.